Case Report: PDF OnlyCoronary Revascularization in a Patient with Immune Thrombocytopenic PurpuraFong, Man-Caia, c; Chen, Kuan-Chuna, c; Leu, Hsin-Banga, c; Chen, Lung-Chingb, c, *Author Information aDivision of Cardiology, Intensive Care Unit, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. bIntensive Care Unit, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. cNational Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C. *Correspondence to: Dr Lung-Ching Chen, Intensive Care Unit, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C. E-mail: [email protected] Received: October 12, 2005; • Accepted: May 24, 2006. Journal of the Chinese Medical Association: September 2006 - Volume 69 - Issue 9 - p 436-438 doi: 10.1016/S1726-4901(09)70287-4 Metrics Abstract Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by premature platelet destruction mediated by autoantibodies. We report a 71-year-old ITP patient with concomitant acute coronary syndrome. Cardiac catheterization was performed through the right radial artery and premedicated with immunoglobulin. Left anterior descending artery was stented, followed by clopidogrel treatment for 7 weeks without major bleeding complication. The patient has been observed for 2 years without clinical restenosis. We suggest that stent implantation is a safe treatment in this special condition. Treatment should be individualized, but it is still a challenge to balance bleeding and thrombosis complication. © 2006 by Lippincott Williams & Wilkins, Inc.